Provident Financial (NYSE:PFS) reported quarterly earnings of $0.53 per share which beat the analyst consensus estimate of $0.52 by 1.92 percent. This is a 8.62 percent decrease over earnings of $0.58 per share from the same period last year.
Bluebird’s Gene Therapy Scores US Approval For Genetic Blood Disorder, Probably The Most Expensive
The FDA has approved Bluebird bio Inc’s (NASDAQ:BLUE) Zynteglo (betibeglogene autotemcel), also known as beti-cel, a one-time gene therapy custom-designed for…
